A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy.
about
The rise of food allergy: Environmental factors and emerging treatmentsBasophil activation test: food challenge in a test tube or specialist research tool?Current Options for the Treatment of Food AllergyRecent advances in immunotherapy and vaccine development for peanut allergyAllergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific ImmunotherapyEAACI Molecular Allergology User's Guide.Molecular approach to allergy diagnosis and therapyOral and sublingual immunotherapy for food allergy: current progress and future directions.Treatments for food allergy: how close are we?Conformational IgE epitopes of peanut allergens Ara h 2 and Ara h 6.Improving the safety of oral immunotherapy for food allergy.Immunotherapy using algal-produced Ara h 1 core domain suppresses peanut allergy in mice.Food allergy: immune mechanisms, diagnosis and immunotherapyEmerging therapies for food allergy.Lactobacillus buchneri S-layer as carrier for an Ara h 2-derived peptide for peanut allergen-specific immunotherapy.Immunotherapy in allergy and cellular tests: state of art.Oral immunotherapy for food allergy: mechanisms and role in management.Modified allergens and their potential to treat allergic disease.Peanut immunotherapy.The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases.Developing therapies for peanut allergy.New developments in immunotherapies for food allergy.Pharmacologic options for the treatment and management of food allergy.Emerging Approaches to Food Desensitization in Children.Current and Emerging Therapies for IgE-Mediated Food Allergy.Application of phage peptide display technology for the study of food allergen epitopes.Future Therapies for IgE-Mediated Food AllergyRecombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy.The current state of food allergy therapeutics.Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical Trials.Allergen-Specific Immunotherapies for Food Allergy.Novel strategies in immunotherapy for allergic diseases.Adjuvanted Immunotherapy Approaches for Peanut Allergy
P2860
Q26744294-E5D10987-232F-490C-9EE1-EB33B0B8D45EQ26765130-3CEFE1C3-9A27-4AA4-97C9-4536A8D73CA9Q26784498-3A75CDDB-A7C7-4869-B795-74A5616E0154Q26796442-71F31D72-2CC1-48BB-A096-CCD0E35A700AQ26852113-7EF85A45-A809-4C57-A177-3E0939403A87Q30276634-A6D93AB8-37C2-4D87-A430-AFD240D74293Q33822511-6070EFCE-F5F4-4B9F-97B4-FF38715CD0E6Q34366285-829DE25F-530D-4911-BE1C-2C7229A3B0FCQ34770744-ADA2C0A0-68F9-4F81-9D89-027EBF5FB9EFQ36033488-680738CD-C287-43C8-8298-9C83C66B4A30Q37106401-6CD30DF7-3FEB-42A5-8BB0-2D35C930A8B1Q37343952-6A0843E2-1C47-4714-B8E9-791195D7560AQ37442005-0674E901-08AA-4CC4-8469-1064C26A8275Q37726651-1EFD4A73-6F19-4DAA-AF34-02751AF8BAE8Q37744450-1F5E8546-23C3-4E63-9AEB-1E2A1BD065F6Q38203380-2249FCCC-A167-4D17-B866-2A7213CB14E3Q38235447-B9121B34-30DD-4533-A7CC-2B2A65546AC1Q38255585-683DF265-94B2-4026-819D-B5A4153928D6Q38256162-93678080-C4FA-47D5-BD56-2542ADDECC16Q38259275-EF83C43F-6232-4FAD-B5E0-1A2315846ABEQ38296706-070925E1-71B8-426D-8310-1DDB13688833Q38565704-5A1EF626-6BF9-4196-AC69-AF1E5A0E65E3Q38569684-857D9FCD-26B6-4230-8260-AC6B1B2B0419Q38692435-AAAA5C74-D7BE-4EE9-94EB-BDEFC4D13CD7Q38760584-AA83D6B5-1274-4DF9-BA61-4558F14451B6Q39044324-3CE03156-6469-4E18-9390-6662D40B1731Q39183051-3E574F4A-1B7B-4960-9A5A-6C1802CACE85Q41769755-13B4EBE6-BBC6-4010-86E0-F5B4300DCFAAQ47690752-E7B8608B-1606-4F11-8AA3-D36D6A486251Q47897158-A2CE1B61-94D1-496E-952C-8BD5259126E7Q49956390-89270B3E-99F1-454C-A87D-6410A14FD787Q55004495-3F40227A-04F3-4575-AD4C-6F55F57CAFA1Q55380934-6FBD8356-E5AD-4BD1-9879-515A5A322E51Q57492025-740E5090-E33A-4726-BC0A-054B1750658B
P2860
A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A phase 1 study of heat/phenol ...... e treatment of peanut allergy.
@en
type
label
A phase 1 study of heat/phenol ...... e treatment of peanut allergy.
@en
prefLabel
A phase 1 study of heat/phenol ...... e treatment of peanut allergy.
@en
P2093
P2860
P356
P1433
P1476
A phase 1 study of heat/phenol ...... e treatment of peanut allergy.
@en
P2093
A K Henning
D Stablein
H A Sampson
R Lindblad
S H Sicherer
P2860
P304
P356
10.1111/ALL.12158
P577
2013-04-29T00:00:00Z